Helmerich & Payne, Inc.HPNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -12.17% |
| Q3 2025 | -2.70% |
| Q2 2025 | -17.45% |
| Q1 2025 | 0.66% |
| Q4 2024 | 5.61% |
| Q3 2024 | -16.04% |
| Q2 2024 | -18.23% |
| Q1 2024 | 49.95% |
| Q4 2023 | 17.50% |
| Q3 2023 | 3.40% |
| Q2 2023 | -18.58% |
| Q1 2023 | 25.52% |
| Q4 2022 | -2.87% |
| Q3 2022 | 9.63% |
| Q2 2022 | 1.94% |
| Q1 2022 | -2.14% |
| Q4 2021 | 25.59% |
| Q3 2021 | -7.36% |
| Q2 2021 | 5.17% |
| Q1 2021 | -4.46% |
| Q4 2020 | 13.59% |
| Q3 2020 | 35.10% |
| Q2 2020 | -41.45% |
| Q1 2020 | -9.65% |
| Q4 2019 | 12.37% |
| Q3 2019 | -13.37% |
| Q2 2019 | -2.70% |
| Q1 2019 | 3.46% |
| Q4 2018 | 39.88% |
| Q3 2018 | -8.41% |
| Q2 2018 | 23.51% |
| Q1 2018 | 37.17% |
| Q4 2017 | -6.59% |
| Q3 2017 | 13.21% |
| Q2 2017 | 12.47% |
| Q1 2017 | -3.17% |
| Q4 2016 | 20.62% |
| Q3 2016 | -14.00% |
| Q2 2016 | 16.93% |
| Q1 2016 | -20.69% |